Adding GLP-1 Receptor Agonist Therapy to Basal Insulin for Postprandial Glucose Control
Open Access
- 1 April 2015
- journal article
- Published by American Diabetes Association in Clinical Diabetes
- Vol. 33 (2) , 73-75
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trialThe Lancet Diabetes & Endocrinology, 2014
- Aace Comprehensive Diabetes Management Algorithm 2013Endocrine Practice, 2013
- Current Issues in Glp-1 Receptor Agonist Therapy for Type 2 DiabetesEndocrine Practice, 2012
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered ApproachDiabetes Care, 2012
- A Stepwise Approach to Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Basal Insulin Treatment FailureEndocrine Practice, 2011
- Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single‐dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugsDiabetes, Obesity and Metabolism, 2008